Reagents for the Qualitative Detection of IgM Antibodies to SARS-CoV-2 by Chemiluminescent Immunoassay (CLIA) in Human Serum and Plasma on ARCHITECT Immunoassay Analyzers

Reagents for the Qualitative Detection of IgM Antibodies to SARS-CoV-2 by Chemiluminescent Immunoassay (CLIA) in Human Serum and Plasma on ARCHITECT Immunoassay Analyzers

This reagent kit is designed for the qualitative determination of IgM antibodies to the SARS-CoV-2 virus using the chemiluminescent immunoassay method in human serum and plasma on ARCHITECT immunoassay analyzers. The product is available in two versions:

Versions:

I. 100-Test Kit, Includes:

• SARS-CoV-2 IgM Microparticles - 1 vial (6.6 ml)
• SARS-CoV-2 IgM Conjugate - 1 vial (5.9 ml)
• SARS-CoV-2 IgM Assay Diluent - 1 vial (11.4 ml)
• Instruction for use

II. 500-Test Kit, Includes:

• SARS-CoV-2 IgM Microparticles - 1 vial (27 ml)
• SARS-CoV-2 IgM Conjugate - 1 vial (26.3 ml)
• SARS-CoV-2 IgM Assay Diluent - 1 vial (40.7 ml)
• Instruction for use

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagents for the Qualitative Detection of IgM Antibodies to SARS-CoV-2 by Chemiluminescent Immunoassay (CLIA) in Human Serum and Plasma on ARCHITECT Immunoassay Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.